Mondi, Annalisa
 Distribuzione geografica
Continente #
EU - Europa 1.517
NA - Nord America 1.307
AS - Asia 732
SA - Sud America 125
AF - Africa 19
AN - Antartide 1
Totale 3.701
Nazione #
US - Stati Uniti d'America 1.264
DE - Germania 408
SG - Singapore 361
PL - Polonia 315
FR - Francia 232
CN - Cina 193
SE - Svezia 168
IT - Italia 126
BR - Brasile 100
UA - Ucraina 89
GB - Regno Unito 63
IN - India 49
IE - Irlanda 40
CA - Canada 30
FI - Finlandia 27
VN - Vietnam 27
ID - Indonesia 25
TR - Turchia 18
AR - Argentina 15
RU - Federazione Russa 15
HK - Hong Kong 10
JP - Giappone 10
BE - Belgio 8
CM - Camerun 8
BD - Bangladesh 7
IR - Iran 7
IQ - Iraq 6
ES - Italia 5
MX - Messico 5
ZA - Sudafrica 5
AT - Austria 4
CL - Cile 3
KR - Corea 3
LT - Lituania 3
NL - Olanda 3
PA - Panama 3
BH - Bahrain 2
CH - Svizzera 2
DK - Danimarca 2
EC - Ecuador 2
JM - Giamaica 2
LU - Lussemburgo 2
PH - Filippine 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AQ - Antartide 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
UY - Uruguay 1
Totale 3.701
Città #
Kraków 310
Chandler 214
Singapore 148
Ashburn 104
Jacksonville 82
New York 69
Dublin 40
San Mateo 40
Ann Arbor 39
Milan 36
Los Angeles 35
Nanjing 35
Redmond 33
Houston 32
Dearborn 30
Beijing 29
Nürnberg 27
Cattolica 26
Jakarta 24
Dallas 23
Wilmington 23
Lawrence 22
Redwood City 20
Boston 19
Lancaster 19
Woodbridge 17
Frankfurt am Main 16
Izmir 16
Nanchang 16
Ottawa 13
The Dalles 12
Changsha 9
Chicago 9
Hefei 9
Hong Kong 9
Tokyo 9
Brussels 8
Hebei 8
Ho Chi Minh City 8
Leawood 8
Munich 8
Rome 8
Seattle 8
Boardman 7
Fairfield 7
Falls Church 7
Lauterbourg 7
London 7
Mountain View 7
Shenyang 7
Buffalo 6
Fremont 6
Hanoi 6
Montreal 6
Norwalk 6
Orem 6
Roubaix 6
Santa Clara 6
Toronto 6
Augusta 5
Brooklyn 5
Guangzhou 5
Jinan 5
Kunming 5
Manchester 5
Moscow 5
Paris 5
São Paulo 5
Tianjin 5
Bari 4
Bexley 4
Phoenix 4
Simi Valley 4
University Park 4
Warsaw 4
Washington 4
Auburn Hills 3
Biên Hòa 3
Busto Arsizio 3
Cambridge 3
Chennai 3
Clearwater 3
Helsinki 3
Johannesburg 3
Kish 3
Marseille 3
Modena 3
Oklahoma City 3
Phủ Lý 3
Poplar 3
Pune 3
Rio de Janeiro 3
San Jose 3
Shanghai 3
Amsterdam 2
Aparecida de Goiânia 2
Atlanta 2
Bologna 2
Bremen 2
Campinas 2
Totale 1.917
Nome #
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 255
Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility 238
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 211
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 206
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 200
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 192
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 183
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 181
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients 178
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 171
Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA 171
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 159
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial 151
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients 141
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 136
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 136
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study 134
Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen 132
Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients. 129
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 119
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons 117
Simplification to a dual regimen with darunavir/ritonavir plus lamivudine or emtricitabine in virologically-suppressed HIV-infected patients 104
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 98
Totale 3.742
Categoria #
all - tutte 12.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.670


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021108 0 0 0 0 0 15 12 5 35 4 32 5
2021/2022258 22 17 9 28 12 18 4 38 12 26 30 42
2022/2023491 75 87 32 74 44 57 7 43 62 0 5 5
2023/2024264 12 77 6 26 15 66 11 0 4 4 30 13
2024/2025463 7 16 26 24 74 15 2 31 96 33 80 59
2025/2026590 139 10 54 137 214 36 0 0 0 0 0 0
Totale 3.742